PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology-Reference-Cited by-同舟云学术

PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology

Published:2019-07 Issue:7 Volume:43 Page:920-927
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Reis Henning,Serrette Rene,Posada Jennifer,Lu Vincent,Chen Ying-bei,Gopalan Anuradha,Fine Samson W.,Tickoo Satish K.,Sirintrapun Sahussapont J.,Iyer Gopa,Funt Samuel A.,Teo Min Yuen,Rosenberg Jonathan E.,Bajorin Dean F.,Dalbagni Guido,Bochner Bernard H.,Solit David B.,Reuter Victor E.,Al-Ahmadie Hikmat A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference35 articles.

1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017

2. Cancer statistics;Siegel;CA Cancer J Clin,2018

3. A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: the future is now;Bellmunt;Cancer Treat Rev,2017

4. Biomarkers for immunotherapy in bladder cancer: a moving target;Aggen;J Immunother Cancer,2017

5. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial;Rosenberg;Lancet,2016

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deutscher Expertenkonsens zur PD-L1-Testung („programmed cell death ligand 1“) in der perioperativen Systemtherapie des muskelinvasiven Blasenkarzinoms;Die Urologie;2024-08-26

2. Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma;Abdominal Radiology;2024-08-02

3. Giant cell carcinoma of the urinary bladder;Virchows Archiv;2024-07-18

4. Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications;International Journal of Molecular Sciences;2024-06-19

5. Evaluation of the Expression of Programmed Death-Ligand 1 and Its Role in Differentiating Low-Grade and High-Grade Urothelial Carcinoma;Cureus;2024-06-17